此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Generating Medical Discharge Report Drafts Via Artificial Intelligence (Letter)

2026年11月12日 更新者:Kepler University Hospital

A key process in intensive care is the creation of transfer reports. These summarize the essential aspects of the treatment to date and ensure that information is passed on to the next treatment team in a structured manner. They contain, among other things, diagnoses, relevant examination results, and therapeutic measures that have been carried out. The aim of a transfer report is to document the patient's medical history and the course of treatment to date in a concise and complete manner. Incomplete transfer reports can lead to repeated examinations, which can potentially delay further therapy and endanger the patient, as well as incurring additional costs.

In this context, a complete transfer report ensures continuity of treatment and contributes significantly to patient safety.

Transfer reports are created from a synthesis of a large number of documents. In addition to medical facts from tables and free-text summaries, physicians also draw on their experience to pass on relevant information to future treatment teams in the synthesis of detailed documentation. This process naturally requires a great deal of time and concentration in patients receiving intensive care.

Artificial intelligence methods, such as large language models (LLMs), could be used to learn how to create transfer reports and formulate drafts.

LLMs can convert unstructured free text into a structured form, thereby facilitating the report creation process. This would make it possible to generate a pre-formulated draft that doctors could then review and supplement.

At present, transfer reports are created by physicians with considerable effort and time. The methods currently available for automating report generation are limited to text modules that largely bundle data sources deterministically. Some of these methods are already commercially available, but they are not capable of creating individual reports beyond form letters.

The automatic analysis of unstructured text data falls within a subfield of AI known as natural language processing (NLP), which also includes language models (LLMs) such as ChatGPT and Gemini, which have been popular since 2022. A major milestone was reached with the development of the Transformer architecture in 2017, which, in addition to the availability of enormous amounts of training data (e.g., Wikipedia, news articles, or books), forms the basis for many groundbreaking language models. The effectiveness of these LLMs is limited for specific domains such as medicine, as the training data often lacks relevant characteristics such as complex terminology or writing styles. Adapting these models for clinical use to improve patient care, research, and medical education is a highly topical field of research. The most relevant foreign-language models include BioBERT, Meditron, and Med-PaLM. As of July 2024, there is only limited research on the development of German-language models, e.g., medBERT, BioGottBERT, and a few models that are not publicly available.

The sole use of LLMs is problematic due to non-reproducible results, lack of transparency, and bias in the models. Knowledge graphs (KGs) are used in medicine to represent and analyze complex information structures. The creation of a "robust digital patient twin" would be improved by the use of LLMs and KGs. This would allow the state of health to be assessed based on all digitally available clinical information (both structured and, in this project, now also unstructured). Recent studies confirm that adapted LLMs in the English language domain can produce summaries that are equivalent to or better than those produced by human experts, and that these are often difficult to distinguish from reports written by humans.

The legal framework for this results from a complex interaction of legal provisions from data protection law (with regard to health data), artificial intelligence law (AI Act), medical law (in particular hospital law), (medical) product law, medical professional law, and other relevant professional groups (e.g., nursing and pharmacy), as well as relevant civil and criminal law standards of care. In addition, there are fundamental rights requirements based on the ECHR and the EU Charter of Fundamental Rights. Data protection issues relating to the use of health data, in particular for research with AI systems, and professional law issues in connection with automated aggregation and presentation have already been examined in detail (as part of the SMARAGD project, FFG 872575).

研究概览

地位

招聘中

条件

研究类型

观察性的

注册 (估计的)

40000

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

    • Upper Austria
      • Linz、Upper Austria、奥地利、4020
        • 招聘中
        • Johannes Kepler University, Kepler University Hospital
        • 接触:
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

取样方法

非概率样本

研究人群

Patients treated in intensive care units.

描述

Inclusion Criteria:

  • Treated in intensive care units between 2008-11-01 to 2025-05-31 at the study center.

Exclusion Criteria:

  • Refusal to participate in scientific studies.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:OTHER
  • 时间观点:RETROSPECTIVE

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Quality of Discharge Report Drafts
大体时间:2008-11-01 to 2025-05-31

Quality of Discharge Report Drafts evaluated based on technical parameters and assessed by human experts.

Factual correctness: Accurate reproduction of e.g. diagnoses, medication versus hallucinations using Entity Matching Score (Percentage of correctly reproduced entities compared with the source data) and Hallucination Rate (Proportion of unverifiable statements).

Completeness: All relevant information is included using checklist compliance (proportion of required fields covered) and Recall against Reference Texts (comparison with physician-written letters, e.g. using ROUGE-L).

Clinical Validity: Recommendations must be evidence-based and consistent with clinical guidelines using guideline-adherence (e.g. rule-based systems or LLM-based assessments).

Structure is assessed with template compliance using NLP-based section recognition.

Data Protection: Degree of Anonymization using NER models. Comprehensibility: Clear, precise language without ambiguities using Readability Assessment.

2008-11-01 to 2025-05-31

次要结果测量

结果测量
措施说明
大体时间
Traceability
大体时间:2008-11-01 to 2025-05-31

The data sources used to create text passages should be visualized so that the steps performed by the AI can be explained and traced. Traceability should also be evaluated by human experts.

2008-11-01 to 2025-05-31
Degree of Necessary Adjustments
大体时间:2008-11-01 to 2025-05-31

The degree of necessary adjustments to drafts should be evaluated proportionally as a percentage of the total text and based on the type of adjustments made by human experts (e.g., spelling errors, content corrections, additions).

2008-11-01 to 2025-05-31

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Thomas Tschoellitsch, MD、Johannes Kepler University

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年4月1日

初级完成 (实际的)

2026年4月1日

研究完成 (估计的)

2029年4月1日

研究注册日期

首次提交

2026年2月25日

首先提交符合 QC 标准的

2026年11月12日

首次发布 (实际的)

2026年11月17日

研究记录更新

最后更新发布 (实际的)

2026年11月17日

上次提交的符合 QC 标准的更新

2026年11月12日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

其他研究编号

  • MEDI-DOK Letter

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅